Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Medicaid fraud verdict

Executive Summary

An Alabama state judge upholds a jury verdict that found AstraZeneca reported false and misleading drug prices for reimbursement by Alabama's state Medicaid agency. Judge Charles Price let stand the $40 million award of compensatory damages but lowered the $175 million punitive damages award to $120 million. The attorney general of Alabama has sued about 70 drug companies alleging Medicaid fraud. The suit against AstraZeneca was the first to go to trial. Novartis and GlaxoSmithKline are currently on trial before Judge Price in Montgomery County Circuit Court
Advertisement

Related Content

Alabama wins second Medicaid fraud verdict
Advertisement
UsernamePublicRestriction

Register

PS049773

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel